Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19

[Image: see text] The global pandemic of SARS-CoV-2, the causative viral pathogen of COVID-19, has driven the biomedical community to action—to uncover and develop antiviral interventions. One potential therapeutic approach currently being evaluated in numerous clinical trials is the agent remdesivi...

Descripción completa

Detalles Bibliográficos
Autores principales: Eastman, Richard T., Roth, Jacob S., Brimacombe, Kyle R., Simeonov, Anton, Shen, Min, Patnaik, Samarjit, Hall, Matthew D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202249/
https://www.ncbi.nlm.nih.gov/pubmed/32483554
http://dx.doi.org/10.1021/acscentsci.0c00489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202249/
https://www.ncbi.nlm.nih.gov/pubmed/32483554
http://dx.doi.org/10.1021/acscentsci.0c00489

Ejemplares similares